Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ethicon expands use of its Mammotome system:

This article was originally published in Clinica

Executive Summary

Ethicon Endo-Surgery, a Johnson and Johnson subsidiary, has expanded the use of its Mammotome breast biopsy system to include X-ray-guided stereotactic (ST) procedures. The Mammotome uses a vacuum-assisted, 11-gauge probe for the partial or complete removal of an imaged abnormality. Currently, doctors guide the probe with ultrasound. The Cincinnati, Ohio company expects to launch the system for X-ray ST procedures separately, or as an upgrade to existing Mammotomes, next month.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel